Rehmann Capital Advisory Group’s West Pharmaceutical WST Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-758
| Closed | -$248K | – | 629 |
|
|
2024
Q4 | $248K | Sell |
758
-17
| -2% | -$5.35K | 0.02% | 517 |
|
|
2024
Q3 | $229K | Sell |
775
-26
| -3% | -$7.96K | 0.02% | 541 |
|
|
2024
Q2 | $264K | Buy |
801
+165
| +26% | +$58.3K | 0.02% | 484 |
|
|
2024
Q1 | $252K | Sell |
636
-12
| -2% | -$4.44K | 0.02% | 498 |
|
|
2023
Q4 | $228K | Hold |
648
| – | – | 0.02% | 504 |
|
|
2023
Q3 | $243K | Sell |
648
-89
| -12% | -$34.4K | 0.02% | 448 |
|
|
2023
Q2 | $282K | Sell |
737
-20
| -3% | -$7.14K | 0.03% | 437 |
|
|
2023
Q1 | $263K | Buy |
+757
| New | +$221K | 0.02% | 450 |
|
|
2022
Q4 | – | Sell |
-816
| Closed | -$201K | – | 582 |
|
|
2022
Q3 | $201K | Buy |
816
+26
| +3% | +$7.92K | 0.02% | 490 |
|
|
2022
Q2 | $239K | Sell |
790
-22
| -3% | -$7.16K | 0.03% | 426 |
|
|
2022
Q1 | $334K | Sell |
812
-16
| -2% | -$6.26K | 0.03% | 386 |
|
|
2021
Q4 | $389K | Sell |
828
-8
| -1% | -$3.44K | 0.04% | 378 |
|
|
2021
Q3 | $355K | Sell |
836
-15
| -2% | -$6.32K | 0.03% | 399 |
|
|
2021
Q2 | $309K | Buy |
851
+33
| +4% | +$10.9K | 0.03% | 424 |
|
|
2021
Q1 | $231K | Sell |
818
-6
| -0.7% | -$1.72K | 0.02% | 470 |
|
|
2020
Q4 | $234K | Buy |
824
+60
| +8% | +$16.8K | 0.03% | 436 |
|
|
2020
Q3 | $210K | Buy |
+764
| New | +$202K | 0.03% | 396 |
|
|
2019
Q3 | $92K | Hold |
649
| – | – | 0.01% | 469 |
|
|
2019
Q2 | $81.2K | Hold |
649
| – | – | 0.01% | 680 |
|
|
2019
Q1 | $71.5K | Buy |
649
+14
| +2% | +$1.46K | 0.01% | 691 |
|
|
2018
Q4 | $62.2K | Hold |
635
| – | – | 0.01% | 523 |
|
|
2018
Q3 | $78.4K | Buy |
635
+32
| +5% | +$3.59K | 0.01% | 657 |
|
|
2018
Q2 | $59.9K | Sell |
603
-34
| -5% | -$3.13K | 0.01% | 715 |
|
|
2018
Q1 | $56K | Buy |
+637
| New | +$59.6K | 0.01% | 724 |
|
Other funds holding WST
DCP
